Global Cell Culture Market Projected to Value Over USD 25.4 Billion by 2026 End

  • 19 Aug 2019

The global cell culture market is estimated to value over USD 25.4 billion and register a CAGR of over 10.8% from the forecast period 2019 to 2026.
The rising demand for bioproduction has led to manufacturers aiming at commercialization and development of many biopharmaceutical products such as therapeutic, monoclonal antibody and vaccines is driving the market. Increasing preference for single-use technologies and increasing funds for cell-based research is accelerating the cell culture market growth. The rise in R&D activity is further expected to spur the market.

The market is classified into by product, application, type, end-user, and region. Based on type, the cell structure is segmented into sera, media & reagents, vessels and bioreactor accessories. Sera, media & reagents are expected to hold a vast share of the market. The rise in the purchase of sera, media, and reagents for multiple biopharmaceutical production, toxicology and vaccine production is boosting the market. Serum-free media eliminates the risk of contamination by viruses. Sera, media, and reagents are an integral part of experiments related to cells as they provide enhanced results.

In terms of application, biopharmaceutical production is expected to hold a major share of the market. The expansion of prominent pharmaceutical companies and increasing regulatory permissions for production of vaccines based on cell culture remains the key factor responsible for the market escalation. Rising demand for monoclonal antibodies is also expanding cell culture market size.

Based on end-users, pharmaceutical and biotechnology companies are expected to showcase exponential growth owing to increasing demand for single-use technologies and growing government approvals towards cell culture-based vaccines. The presence of an ample number of pharmaceutical players is also positively influencing the market.

In terms of regions, North America is the global leader of the market. Government and private enterprises rising interest in vaccines related to cell culture and higher investments in cell-based research are driving the growth of the market in the region. Growing prevalence regarding the latest trends in cell culture technology and rapid expansion of pharmaceutical industries is bolstering the market. Asia-Pacific region is also expected to show significant growth due to strong support from the governments of Japan, China, and India. The strategic developments made by prominent players are expected to boost the presence of the market in Japan. The increasing initiative by the Indian government to promote life science industry is escalating the market in the region.

Prominent players of the market are Lonza, Becton, Dickinson, and Company, Merck KGaA, Corning Incorporated, CellGenix GmbH, Eppendorf AG, PromoCell GmbH, GE Healthcare, HiMedia Laboratories, Sartorius AG, InvivoGen and Irvine Scientific.

Competitive Landscape:
●     Thermo Fisher Scientific in 2019 invested USD 150 million to expand its capacity of lyophilized product development and sterile liquids. Their centres across Italy and the US will have aseptic filling lines alongside isolator technology which will help in strengthening the company's customer base worldwide
●     Merck in 2018 opened its BioReliance biosafety testing lab in Singapore. Their new lab will offer critical testing services which would further augment the market

FutureWise Key Takeaways
●     According to our industry experts, single-use bioreactors are expected to witness immense demand owing to the rising adoption of single-use technologies. Single-use technologies offer benefits such as low price and low contamination risk. In addition, the demand for mAbs is also fueling the demand of single-use bioreactors thus propelling the market
●     Europe is expected to be a high growth profit region owing to the growing support of private investors and the government for R&D activity in countries like Germany and France. Expansion of the life science industry in the UK is also positively influencing the market

Global Cell Culture Market Segmentation 
By Product 

●     Consumables 
▪      Sera, Media and Reagents
▪      Vessels
▪      Bioreactor Accessories 

●     Equipment 
▪      Supporting Equipment 
▪      Bioreactors 
▪      Storage Equipment 

By Application 
●     Biopharmaceutical Production 
●     Diagnostics 
●     Drug Screening and Development
●     Stem Cell Research 
●     Tissue Engineering & Regenerative Medicine

By End-User 
●     Pharmaceutical & Biotechnology Companies
●     Hospitals and Diagnostic Laboratories 
●     Research Institutes

By Region
●     North America
●     Europe
●     Asia Pacific
●      Latin America
●     Rest of the World

Objectives of the Study:
• To provide with an exhaustive analysis on the global cell culture market by product, by application, by end-user, and by region
• To cater to comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers, and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact